Inactivated parapoxvirus ovis activates canine blood phagocytes and T lymphocytes

Veterinary Microbiology

Volumn 137, Issue 3-4, 2009, Pages 260-267

  Schütze, Nicole ^a   Raue, Rüdiger ^b   Büttner, Mathias ^c   Alber, Gottfried ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c Bavarian Health and Food Safety Authority   (Germany)

Author keywords

Cell activation; Monocyte macrophages; Oxidative burst; Phagocytosis; Virus

Indexed keywords

CD14 ANTIGEN; INACTIVATED PARAPOXVIRUS OVIS VACCINE; INACTIVATED VIRUS VACCINE; UNCLASSIFIED DRUG; ZYLEXIS;

ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; DOG; DRUG EFFECT; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LYMPHOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL; NONHUMAN; PARAPOXVIRUS; PARAPOXVIRUS OVIS; PHAGOCYTOSIS; RESPIRATORY BURST; VIRUS INACTIVATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DOGS; GENES, MHC CLASS II; LYMPHOCYTE ACTIVATION; PARAPOXVIRUS; PHAGOCYTES; PHAGOCYTOSIS; RESPIRATORY BURST; T-LYMPHOCYTES; UP-REGULATION; VIRUS INACTIVATION;

CANIS FAMILIARIS; LISTERIA MONOCYTOGENES; OVIS; PARAPOXVIRUS;

EID: 67349185047     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.01.035     Document Type: Article

References (43)

1. Blanchette J., Jaramillo M., and Olivier M. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology 108 (2003) 513-522
2. Burgers W.A., Shephard E., Monroe J.E., Greenhalgh T., Binder A., Hurter E., Van Harmelen J.H., Williamson C., and Williamson A.L. Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C. AIDS Res. Hum. Retroviruses 24 (2008) 195-206
3. Büttner M., Czerny C.P., Lehner K.H., and Wertz K. Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs. Vet. Immunol. Immunopathol. 46 (1995) 237-250
4. Büttner M., and Rziha H.J. Parapoxviruses: from the lesion to the viral genome. J. Vet. Med. B Infect. Dis. Vet. Public Health 49 (2002) 7-16
5. Castrucci G., Osburn B.I., Frigeri F., Ferrari M., Salvatori D., Lo D.M., and Barreca F. The use of immunomodulators in the control of infectious bovine rhinotracheitis. Comp. Immunol. Microbiol. Infect. Dis. 23 (2000) 163-173
6. Cobbold S., and Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 43 (1994) 137-154
7. Cottone R., Büttner M., Bauer B., Henkel M., Hettich E., and Rziha H.J. Analysis of genomic rearrangement and subsequent gene deletion of the attenuated Orf virus strain D1701. Virus Res. 56 (1998) 53-67
8. Cross C.E., Collins H.L., and Bancroft G.J. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology 91 (1997) 289-296
9. Deane D., McInnes C.J., Percival A., Wood A., Thomson J., Lear A., Gilray J., Fleming S., Mercer A., and Haig D. Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. J. Virol. 74 (2000) 1313-1320
10. Drozina G., Kohoutek J., Jabrane-Ferrat N., and Peterlin B.M. Expression of MHC II genes. Curr. Top. Microbiol. Immunol. 290 (2005) 147-170
11. Egan C.E., Sukhumavasi W., Bierly A.L., and Denkers E.Y. Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection. Immunol. Res. 40 (2008) 35-48
12. Fachinger V., Schlapp T., and Saalmüller A. Evidence for a parapox ovis virus-associated superantigen. Eur. J. Immunol. 30 (2000) 2962-2971
13. Fachinger V., Schlapp T., Strube W., Schmeer N., and Saalmüller A. Poxvirus-induced immunostimulating effects on porcine leukocytes. J. Virol. 74 (2000) 7943-7951
14. Förster R., Wolf G., and Mayr A. Highly attenuated poxviruses induce functional priming of neutrophils in vitro. Arch. Virol. 136 (1994) 219-226
15. Friebe A., Siegling A., Friederichs S., Volk H.D., and Weber O. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J. Virol. 78 (2004) 9400-9411
16. Gherardi M.M., and Esteban M. Recombinant poxviruses as mucosal vaccine vectors. J. Gen. Virol. 86 (2005) 2925-2936
17. Haig D.M., and Fleming S. Immunomodulation by virulence proteins of the parapoxvirus orf virus. Vet. Immunol. Immunopathol. 72 (1999) 81-86
18. Haig D.M., McInnes C., Deane D., Reid H., and Mercer A. The immune and inflammatory response to orf virus. Comp. Immunol. Microbiol. Infect. Dis. 20 (1997) 197-204
19. Haig D.M., and McInnes C.J. Immunity and counter-immunity during infection with the parapoxvirus orf virus. Virus Res. 88 (2002) 3-16
20. Haig D.M., and Mercer A.A. Ovine diseases. Orf. Vet. Res. 29 (1998) 311-326
21. Ibisch C., Pradal G., Bach J.M., and Lieubeau B. Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker. J. Immunol. Methods 298 (2005) 175-182
22. Imlach W., McCaughan C.A., Mercer A.A., Haig D., and Fleming S.B. Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J. Gen. Virol. 83 (2002) 1049-1058
23. Irwin M.J., Hudson K.R., Fraser J.D., and Gascoigne N.R. Enterotoxin residues determining T-cell receptor V beta binding specificity. Nature 359 (1992) 841-843
24. Kato M., Watarai S., Nishikawa S., Iwasaki T., and Kodama H. A novel culture method of canine peripheral blood lymphocytes with concanavalin a and recombinant human interleukin-2 for adoptive immunotherapy. J. Vet. Med. Sci. 69 (2007) 481-486
25. Lateef Z., Fleming S., Halliday G., Faulkner L., Mercer A., and Baird M. Orf virus-encoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J. Gen. Virol. 84 (2003) 1101-1109
26. Lloyd J.B., Gill H.S., Haig D.M., and Husband A.J. In vivo T-cell subset depletion suggests that CD4+ T-cells and a humoral immune response are important for the elimination of orf virus from the skin of sheep. Vet. Immunol. Immunopathol. 74 (2000) 249-262
27. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171 (1994) 131-137
28. Mayr A., Herlyn M., Mahnel H., Danco A., Zach A., and Bostedt H. Control of contagious ecthyma in sheep by means of a new paranteral cell culture derived live vaccine. J. Med. Vet. B (1981) 535-549
29. McKeever D.J., Jenkinson D.M., Hutchison G., and Reid H.W. Studies of the pathogenesis of orf virus infection in sheep. J. Comp. Pathol. 99 (1988) 317-328
30. Mercer J., and Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320 (2008) 531-535
31. Mielcarek M., Kucera K.A., Nash R., Torok-Storb B., and McKenna H.J. Identification and characterization of canine dendritic cells generated in vivo. Biol. Blood Marrow Transplant. 13 (2007) 1286-1293
32. Nascimbeni M., Shin E.C., Chiriboga L., Kleiner D.E., and Rehermann B. Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 104 (2004) 478-486
33. Peres C.M., Aronoff D.M., Serezani C.H., Flamand N., Faccioli L.H., and Peters-Golden M. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. J. Immunol. 179 (2007) 5454-5461
34. Renno T., Attinger A., Locatelli S., Bakker T., Vacheron S., and MacDonald H.R. Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J. Immunol. 162 (1999) 6312-6315
35. Roberts J., and Camacho Z. Oxidation of NADPH by polymorphonuclear leucocytes during phagocytosis. Nature 216 (1967) 606-607
36. Rothe G., Oser A., and Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 75 (1988) 354-355
37. Scagliarini A., Dal P.F., Gallina L., Guercio A., Vaccari F., Battilani M., Ciulli S., and Prosperi S. In vitro activity of VEGF-E produced by orf virus strains isolated from classical and severe persistent contagious ecthyma. Vet. Microbiol. 114 (2006) 142-147
38. Serbina N.V., Jia T., Hohl T.M., and Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26 (2008) 421-452
39. Voigt H., Merant C., Wienhold D., Braun A., Hutet E., Le Potier M.F., Saalmüller A., Pfaff E., and Büttner M. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine 25 (2007) 5915-5926
40. Wang Y.S., Chi K.H., Liao K.W., Liu C.C., Cheng C.L., Lin Y.C., Cheng C.H., and Chu R.M. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation. Can. J. Vet. Res. 71 (2007) 165-174
41. Weber O., Siegling A., Friebe A., Limmer A., Schlapp T., Knolle P., Mercer A., Schaller H., and Volk H.D. Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J. Gen. Virol. 84 (2003) 1843-1852
42. Yirrell D.L., Reid H.W., Norval M., Entrican G., and Miller H.R. Response of efferent lymph and popliteal lymph node to epidermal infection of sheep with orf virus. Vet. Immunol. Immunopathol. 28 (1991) 219-235
43. Ziebell K.L., Steinmann H., Kretzdorn D., Schlapp T., Failing K., and Schmeer N. The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses. Zentralbl. Veterinarmed. B 44 (1997) 529-536